
DBS Reaffirms Their Buy Rating on COSCO SHIPPING Energy Transportation Co (CSDXF)
In a report released today, Jason Sum from DBS maintained a Buy rating on COSCO SHIPPING Energy Transportation Co (CSDXF – Research Report), with a price target of HK$9.60. The company's shares closed last Thursday at $0.81.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Sum is a 4-star analyst with an average return of 11.0% and a 63.79% success rate. Sum covers the Industrials sector, focusing on stocks such as COSCO SHIPPING Holdings Co, SIA Engineering Co, and Boeing.
Currently, the analyst consensus on COSCO SHIPPING Energy Transportation Co is a Moderate Buy with an average price target of $1.12.
The company has a one-year high of $1.50 and a one-year low of $0.62. Currently, COSCO SHIPPING Energy Transportation Co has an average volume of 205.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Digital Payment Update - Open Banking Fuels Fintech Surge in the Middle East
Recent developments in digital payment integration highlight the transformative impact of Open Banking in the Middle East, as detailed in a new white paper by TPAY MOBILE. The document emphasizes how innovative financial technologies, coupled with updated licensing and increased investment, are spurring rapid fintech growth in the region. Despite relatively lower valuations compared to Western markets, the Middle East's strategic position and Open Banking's potential to create seamless digital experiences present significant profit opportunities. These changes are contributing to the expected global increase in digital payment adoption, with digital wallet users projected to reach over 5.2 billion by 2026. In other market news, was trading firmly up 3% and finishing the session at HK$5.42, close to the 52-week high. In the meantime, lagged, down 7.7% to end trading at $323.25. Corpay's strategic M&A activity and potential divestitures target rapid growth in Corporate Payments. Discover more about Corpay's expansion strategy in our in-depth narrative. ended the day at $352.85 down 5%. ended the day at $70.83 down 5.3%. ended the day at $14.09 down 5.4%. Navigate through the entire inventory of 200 Digital Payment Stocks including Shinhan Financial Group, Mega Financial Holding and BOC Hong Kong (Holdings) here. Seeking Other Investments? The latest GPUs need a type of rare earth metal called Dysprosium and there are only 24 companies in the world exploring or producing it. Find the list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sources: Simply Wall St "tpay Releases White Paper on the Transformative Power of Open Banking Across the Middle East" from TPAY MOBILE on GlobeNewswire (published 11 June 2025) Companies discussed in this article include SEHK:1658 NYSE:V NasdaqGS:PYPL NasdaqGS:SOFI and NYSE:CPAY. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@


Business Insider
2 hours ago
- Business Insider
TD Cowen Remains a Hold on Paychex (PAYX)
In a report released today, Bryan Bergin from TD Cowen maintained a Hold rating on Paychex (PAYX – Research Report), with a price target of $153.00. The company's shares closed last Friday at $153.22. Confident Investing Starts Here: Bergin covers the Technology sector, focusing on stocks such as Accenture, Cognizant, and Exlservice Holdings. According to TipRanks, Bergin has an average return of 2.5% and a 49.28% success rate on recommended stocks. Currently, the analyst consensus on Paychex is a Hold with an average price target of $169.14, which is a 10.39% upside from current levels. In a report released on June 10, Morgan Stanley also maintained a Hold rating on the stock with a $150.00 price target. PAYX market cap is currently $55.19B and has a P/E ratio of 31.86. Based on the recent corporate insider activity of 76 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PAYX in relation to earlier this year. Most recently, in April 2025, Michael Gioja, the SVP of PAYX sold 31,653.00 shares for a total of $4,893,136.23.


Business Insider
4 hours ago
- Business Insider
Oppenheimer Remains a Buy on Nurix Therapeutics (NRIX)
Oppenheimer analyst Matthew Biegler reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) yesterday and set a price target of $32.00. The company's shares closed last Friday at $11.93. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Biegler is an analyst with an average return of -12.1% and a 31.68% success rate. Biegler covers the Healthcare sector, focusing on stocks such as Gilead Sciences, Regeneron, and Nurix Therapeutics. In addition to Oppenheimer, Nurix Therapeutics also received a Buy from Truist Financial's Srikripa Devarakonda in a report issued on June 13. However, on June 3, Leerink Partners reiterated a Hold rating on Nurix Therapeutics (NASDAQ: NRIX).